1. Home
  2. Angel / Venture

Category: Pharma and Healthcare

UK biotech firms extend rush to US stock market

Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore,

New Horizon covers IPO books

Medical device manufacturer New Horizon Health has pulled in early demand to cover its Hong Kong IPO multiple times over, according to a source familiar with the matter.

Charlesbank Hits Hard Cap

Charlesbank Capital Partners has held a final closing of its newest flagship fund, Charlesbank Equity Fund X LP, at its hard cap with $3.75 billion of capital. Fundraising for the new fund was launch just

Soleus leads $35m series-C extension for Inivata

Soleus Capital has led a $35m series-C funding round extension in cancer genomics company Inivata.

New Horizon launches $263m Hong Kong listing

New Horizon Health hit the equities market on Thursday, aiming to raise up to HK$2.04bn ($263.1m) from its IPO, according to a source familiar with the matter.

BGF sells Renal Services

BGF has sold dialysis services provider Renal Services to healthcare group DaVita UK.

GHO appoints Miller, Hamilton-Fairley as operating partners

Global Healthcare Opportunities (GHO) has appointed David W Miller and Geoffrey Hamilton-Fairley as operating partners.

Healthcare M&A Transaction Recap for the Year 2020

Mertz Taggart reaches a new milestone of over 100 successfully completed transactions.(PRWeb February 04, 2021)Read the full story at https://www.prweb.com/releases/healthcare_m_a_transaction_recap_for_the_year_2020/prweb17706450.htm

WuXi Bio, InnoCare tap equity investors for HK$16bn

Chinese biopharmaceutical duo WuXi Biologics (Cayman) and InnoCare Pharma raised a combined HK$16.2bn ($2.1bn) on Tuesday from selling new stock.

Carlyle, Brighton Park back Bangalore-based health, biotech commercialisation services provider Indegene

Private equity giant Carlyle has teamed with with Brighton Park Capital to invest in Bangalore-headquartered enterprise healthtech solutions provider Indegene.

CVC buys Shiseido personal care unit in $1.5bn deal

The operations divested from the Japanese business include Shiseido’s well-known drugstore brands, such as Tsubaki hair care products and Senka face wash

Moonpig delivers IPO investors a gift on day one

Moonpig, the online greetings card company, was trading over 20% above its IPO price on Tuesday, netting a healthy profit for investors and showing another example of IPO resilience amidst recent equity market volatility.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.